Skip to content

CoMiTED: investigating whether a collapsed lung (pneumothorax) due to injury (trauma) can be safely and effectively treated without immediately inserting a tube into the chest (chest drain)

Conservative Management in Traumatic Pneumothoraces in the Emergency Department (CoMiTED): A Randomised Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN35574247
Enrollment
400
Registered
2022-07-04
Start date
2022-08-08
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic pneumothorax Injury, Occupational Diseases, Poisoning

Interventions

Participants will be allocated in a 1:1 ratio to either “initial conservative management (intervention group)” or “chest drain insertion in the ED (control group)”. Randomisation will be carried out

Sponsors

North Bristol NHS Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Presenting to the Emergency Department with traumatic pneumothoraces 2. Aged, or believed to be aged, =16 years 3. The treating clinician(s) are uncertain if a chest drain is required

Exclusion criteria

Exclusion criteria: 1. Treating clinician(s) believe injuries are incompatible with life 2. Respiratory arrest 3. Haemothorax requiring a chest drain in the opinion of the treating clinician(s) 4. Clinical and imaging evidence of tension pneumothorax 5. Prisoners (does not include those in police custody; only those detained in prison establishments) 6. Retrospective paediatric exclusion if patient confirmed to be aged <16 years

Design outcomes

Primary

MeasureTime frame
Need for one or more subsequent emergency pleural interventions (excluding chest drain insertion in the ED) measured using patient records/electronic patient tracking systems up to 30 days

Secondary

MeasureTime frame
The following will be measured at specified timepoints post-randomisation: 1. All pleural interventions (including chest drain insertion in the ED) measured using patient records/electronic patient tracking systems up to 30 days 2. All complications of pleural intervention measured using patient records/electronic patient tracking systems up to 30 days 3. Total days of pleural drainage measured using patient records/electronic patient tracking systems up to 30 days 4. Patient-reported pain, function, and breathlessness measured using validated Brief Pain Inventory and MRC dyspnoea scale (Patient Reported Outcome Measures) at baseline, 30 days, 3 and 6 months 5. Quality of life measured using EQ-5D-5L questionnaire and Impact of Events Scale-Revised at 30 days, 3 and 6 months 6. Total length of stay (hospital and Intensive Care Unit (ICU), including readmission) measured using patient records/electronic patient tracking systems up to 30 days 7. Adjudicated mortality (pneumothorax or chest injury related) measured using patient records/electronic patient tracking systems at 30 days 8. All-cause mortality measured using patient records/electronic patient tracking systems at 6 months 9. Cost per quality-adjusted life year (QALY) measured using the data collected in secondary outcomes "1., 2., 4., 5., 6., 7., and 8." supplemented by a study-specific patient resource use questionnaire at 6 months 10. Patient/consultee views and experiences of conservative management/chest drain measured using qualitative interviews at 30 days and 6 months 11. Clinician views of conservative management/chest drain measured using qualitative interviews throughout the trial

Countries

England, Northern Ireland, Scotland, United Kingdom, Wales

Contacts

Public ContactNikki Blythe
comited-trial@bristol.ac.uk+44 (0)117 394 0250

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 6, 2026